Nanomics

Based in Hangzhou, China, and established in 2021, Nanomics is a biotechnology company that focuses on the proteomics field. The company's founder is Dr. Hao Wu who majored in molecular engineering at the Chicago University. And the company's co-founder is Dr.

Le Shen, who is an associate professor at the Chicago, University, and has 20 years of research and translational experience in molecular pathology and multi-omics. Moreover, the company has 1,000 square meters laboratory in Hangzhou, and has established cooperation with Tsinghua University, tertiary hospitals. The company developed a high-throughput automation technology platform, Kepler Pro, which covered a whole of the testing procedure. The Kepler Pro platform established a relational library between nanoprobe and protein, based on a high-throughput microfluidics platform NanoFactory, then collecting data based on the automatic sample processing workstation, NanoRobot, after performing data analysis based on the bioinformatics platform, NanoOmics.

The company's microfluidics platform and nanoengineering platform can support the design, synthesis, and screen of tens of thousands of nanoprobes with unique physical structures. Furthermore, the company is exploring the knowledge graphs between nano and Proteome, using the technology of deep learning algorithms. The company's revenue streams are based on providing testing reagent and testing consumables, automation workstations, and proteomics platforms for researchers who worked in biomarker and drugs discovery. The company plans to R&D high-throughput labor party cabin, and bio information software platform, and to the production of reagent and testing consumables.